This video episode in our Grand Rounds series is a thirteen-minute excerpt from our hour-long presentation on pituitary surgery. It focuses on the current practice by some surgeons that consider surgery for pituitary tumors in the cavernous sinus and discusses the procedure’s issues, benefits, pitfalls, and risks.
From J D Faccinetti, co-founder – It is often said that once you know people with acromegaly, you will see it more often. It makes you wonder how apt the definition of “rare” is for
From the desk of Jorge D Faccinetti, co-founder: I can’t help but think that raising awareness for acromegaly would be easier with a different name. My branding instincts tell me that this name is doing
We often scan the pituitary universe and report on the latest drug developments, new potential therapies, and engaging clinical cases and resources. We hope this knowledge helps people gain more insight into these complicated diseases and the fascinating medical/scientific discovery, research, and diagnosis world.
Ana’s work to push forward to get a diagnosis and understand what was going on with her, led to a diagnosis that might have been otherwise considerably delayed.
There is an urgent world need for people with DI/Vasopressin Deficiency to understand and better manage this condition. The advocacy community, including the World Alliance of Pituitary Organizations – WAPO, the Got DI/AVP patient community,
Thanks to the lovely algorithms social media is using, we may only reach some of you with some posts, so here are a few of our latest articles and podcasts. We always encourage you to
From J D Faccinetti, Co-founder and Chief Editor – When you deal with a chronic pituitary disease, you get close to your medications, just like you would to a friend. This was my experience with
UCSF Neurosurgeon Dr. Manish Aghi, MD, Ph.D. Professor of Neurological Surgery UCSF Weill Institute for Neurosciences presents “Endoscopic surgery for sellar and parasellar tumors – Lessons learned in the OR and laboratory.”
San Diego, California-based Crinetics Pharmaceutical announced today that its novel investigational drug paltusotine maintained IGf-1 levels in patients who switched from monthly injectables
In a recent JAMA Network article covering the COVID-19 pandemic, 23.3% of physicians reported personal attacks on social media. Online bullying and social media harassment are nothing new, but this behavior, plus considerable misinformation, makes disseminating helpful, accurate content an ongoing challenge.